Silvercrest Asset Management Group LLC Novartis Ag Transaction History

Silvercrest Asset Management Group LLC

$13.6 Billion
Q2 2024

A detailed history of Silvercrest Asset Management Group LLC transactions in Novartis Ag stock. As of the latest transaction made, Silvercrest Asset Management Group LLC holds 10,244 shares of NVS stock, worth $1.18 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

10,244

Previous 20,488 50.0%

Holding current value

$1.18 Million

Previous $2.18 Million 50.02%

% of portfolio

0.01%

Previous 0.01%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$92.57 - $107.37 $948,287 - $1.1 Million	-10,244 Reduced 50.0%	10,244 $1.09 Million
Q2 2024 Aug 14, 2024	BUY	$92.57 - $107.37 $878,859 - $1.02 Million	9,494 Added 86.36%	20,488 $2.18 Million
Q1 2024 May 15, 2024	BUY	$95.27 - $108.47 $47,635 - $54,235	500 Added 4.76%	10,994 $1.06 Million
Q4 2023 Feb 14, 2024	SELL	$92.27 - $101.54 $1,014 - $1,116	-11 Reduced 0.1%	10,494 $1.06 Million
Q2 2023 Aug 14, 2023	SELL	$92.52 - $104.91 $47,740 - $54,133	-516 Reduced 4.68%	10,505 $1.06 Million
Q4 2022 Feb 14, 2023	SELL	$75.55 - $92.52 $12,616 - $15,450	-167 Reduced 1.49%	11,021 $999,000
Q2 2022 Aug 15, 2022	SELL	$80.52 - $93.75 $10,065 - $11,718	-125 Reduced 1.1%	11,188 $946,000
Q1 2022 May 16, 2022	SELL	$80.11 - $90.62 $29,079 - $32,895	-363 Reduced 3.11%	11,313 $993,000
Q4 2021 Feb 14, 2022	BUY	$79.7 - $88.13 $3,028 - $3,348	38 Added 0.33%	11,676 $1.02 Million
Q3 2021 Nov 15, 2021	SELL	$81.78 - $95.14 $81,289 - $94,569	-994 Reduced 7.87%	11,638 $952,000
Q2 2021 Aug 16, 2021	SELL	$85.24 - $94.15 $10,740 - $11,862	-126 Reduced 0.99%	12,632 $1.15 Million
Q1 2021 May 17, 2021	SELL	$83.5 - $98.47 $2,421 - $2,855	-29 Reduced 0.23%	12,758 $1.09 Million
Q4 2020 Feb 16, 2021	BUY	$78.07 - $94.43 $26,465 - $32,011	339 Added 2.72%	12,787 $1.21 Million
Q3 2020 Nov 16, 2020	BUY	$82.14 - $91.0 $2,382 - $2,639	29 Added 0.23%	12,448 $1.08 Million
Q2 2020 Aug 14, 2020	BUY	$80.93 - $91.1 $27,839 - $31,338	344 Added 2.85%	12,419 $1.09 Million
Q1 2020 May 15, 2020	BUY	$70.67 - $99.01 $53,567 - $75,049	758 Added 6.7%	12,075 $996,000
Q4 2019 Feb 14, 2020	BUY	$84.35 - $95.37 $4,301 - $4,863	51 Added 0.45%	11,317 $1.07 Million
Q2 2019 Aug 14, 2019	BUY	$75.4 - $92.8 $56,550 - $69,600	750 Added 7.13%	11,266 $1.03 Million
Q1 2019 May 15, 2019	SELL	$75.32 - $86.15 $602 - $689	-8 Reduced 0.08%	10,516 $1.01 Million
Q4 2018 Feb 14, 2019	SELL	$73.66 - $82.02 $10,975 - $12,220	-149 Reduced 1.4%	10,524 $903,000
Q3 2018 Nov 14, 2018	BUY	$66.94 - $77.43 $163,668 - $189,316	2,445 Added 29.72%	10,673 $920,000
Q2 2018 Aug 14, 2018	BUY	$64.91 - $73.36 $6,036 - $6,822	93 Added 1.14%	8,228 $622,000
Q4 2017 Feb 14, 2018	SELL	$72.33 - $77.64 $21,699 - $23,292	-300 Reduced 3.56%	8,135 $683,000
Q3 2017 Nov 14, 2017	BUY	$74.14 - $77.27 $625,370 - $651,772	8,435	8,435 $724,000

Others Institutions Holding NVS

# of Institutions

1,426

Shares Held

138M

Call Options Held

1.48M

Put Options Held

1.54M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $249B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Silvercrest Asset Management Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Silvercrest Asset Management Group LLC with notifications on news.

Account

Silvercrest Asset Management Group LLC Novartis Ag Transaction History